Carregant...
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
Postmenopausal women are at an increased risk of osteopenia and osteoporosis due to the physiologic loss of the bone protective effects of estrogen. Additionally, disease-related risk factors also contribute to the increased fracture risk. To further complicate matters, one of the most common and se...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger GmbH
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132952/ https://ncbi.nlm.nih.gov/pubmed/21779210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000321426 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|